β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma - Carbonell, W S; DeLay, M; Jahangiri, A; Park, C C; Aghi, M K (Cancer Res, 2013)